These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10537283

  • 1. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
    Hodge JW, Schlom J.
    Cancer Res; 1999 Oct 15; 59(20):5106-11. PubMed ID: 10537283
    [Abstract] [Full Text] [Related]

  • 2. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J.
    Clin Cancer Res; 2003 May 15; 9(5):1837-49. PubMed ID: 12738742
    [Abstract] [Full Text] [Related]

  • 3. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM, Schlom J, Hodge JW.
    Cancer Res; 2002 Oct 15; 62(20):5770-7. PubMed ID: 12384537
    [Abstract] [Full Text] [Related]

  • 4. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
    Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA.
    Cancer Res; 1995 Aug 15; 55(16):3598-603. PubMed ID: 7543017
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene.
    Tao G, Hu J, Zou H, Lin Q, Liu F, Wu Y, Sun Q.
    Chin Med J (Engl); 2001 Jun 15; 114(6):623-7. PubMed ID: 11780440
    [Abstract] [Full Text] [Related]

  • 6. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
    Hodge JW, Poole DJ, Aarts WM, Gómez Yafal A, Gritz L, Schlom J.
    Cancer Res; 2003 Nov 15; 63(22):7942-9. PubMed ID: 14633725
    [Abstract] [Full Text] [Related]

  • 7. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
    Grosenbach DW, Barrientos JC, Schlom J, Hodge JW.
    Cancer Res; 2001 Jun 01; 61(11):4497-505. PubMed ID: 11389081
    [Abstract] [Full Text] [Related]

  • 8. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 9. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 10. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.
    Hodge JW, Abrams S, Schlom J, Kantor JA.
    Cancer Res; 1994 Nov 01; 54(21):5552-5. PubMed ID: 7522961
    [Abstract] [Full Text] [Related]

  • 11. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K, Tüting T, Tahara H, Lotze MT.
    Gene Ther; 1999 Dec 01; 6(12):1988-94. PubMed ID: 10637450
    [Abstract] [Full Text] [Related]

  • 12. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules.
    Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J.
    Clin Cancer Res; 2005 Feb 15; 11(4):1597-607. PubMed ID: 15746065
    [Abstract] [Full Text] [Related]

  • 13. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
    Si SY, Hu PZ, Huang YY, Ye J, Huang Y, Li ZS, Ge W, Li X, Qu P, Zhang XM, Sui YF.
    Biochem Biophys Res Commun; 2006 Aug 18; 347(1):208-14. PubMed ID: 16814254
    [Abstract] [Full Text] [Related]

  • 14. Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.
    Kudo-Saito C, Schlom J, Hodge JW.
    Clin Cancer Res; 2005 Mar 15; 11(6):2416-26. PubMed ID: 15788693
    [Abstract] [Full Text] [Related]

  • 15. A triad of costimulatory molecules synergize to amplify T-cell activation.
    Hodge JW, Sabzevari H, Yafal AG, Gritz L, Lorenz MG, Schlom J.
    Cancer Res; 1999 Nov 15; 59(22):5800-7. PubMed ID: 10582702
    [Abstract] [Full Text] [Related]

  • 16. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY, Zhu M, Even J, Gulley J, Arlen P, Schlom J.
    Cancer Res; 2001 Oct 15; 61(20):7568-76. PubMed ID: 11606396
    [Abstract] [Full Text] [Related]

  • 17. Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.
    Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC.
    Gene Ther; 2001 Jan 15; 8(2):128-38. PubMed ID: 11313782
    [Abstract] [Full Text] [Related]

  • 18. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH, BANG HS, CHO HW, CHUNG YH.
    Acta Virol; 2007 Jan 15; 51(2):125-30. PubMed ID: 17900219
    [Abstract] [Full Text] [Related]

  • 19. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C, Sanda MG.
    Curr Opin Mol Ther; 1999 Aug 15; 1(4):471-9. PubMed ID: 11713762
    [Abstract] [Full Text] [Related]

  • 20. Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine.
    Chatterjee SK, Qin H, Manna S, Tripathi PK.
    Anticancer Res; 1999 Aug 15; 19(4B):2869-73. PubMed ID: 10652566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.